Medicare Enrolled
Dr. Phillip Ginsberg, D.O.
Optician · Philadelphia, PA
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Speaking/Promotional
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Ginsberg from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Ginsberg?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Ginsberg
Dr. Phillip Ginsberg is an optician specialist in Philadelphia, PA, with 20 years of NPI registration. Based on federal Medicare data, Dr. Ginsberg performed 20,083 Medicare services across 3,877 unique beneficiaries.
Between the years covered by Open Payments, Dr. Ginsberg received a total of $122,971 from 63 pharmaceutical and/or device companies across 951 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in optician. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Ginsberg is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice
▲ Top 1% volume in PA
$122,971 industry payments
Medicare Practice Summary
Medicare Utilization ↗20,083
Medicare services
Top 1% in PA for optician
3,877
Unique beneficiaries
$12
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~1,004 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Testosterone injection An injection of testosterone cypionate, a form of testosterone hormone. The dose is measured in milligrams. |
14,600 | $0 | $0 |
| Bladder ultrasound after voiding An ultrasound scan performed after urination to measure the amount of urine remaining in the bladder. |
982 | $8 | $67 |
| Urinalysis, manual A manual laboratory examination of a urine sample to check for various substances and cells. |
830 | $3 | $8 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
662 | $92 | $342 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
649 | $67 | $243 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
383 | $8 | $11 |
| Limited abdominal ultrasound A focused ultrasound examination of the abdomen to evaluate specific organs or areas. This procedure uses sound waves to create images of internal structures. |
308 | $68 | $245 |
| Limited ultrasound of pelvis A focused ultrasound exam of the pelvic area to evaluate specific structures. This procedure provides images of the pelvis to assist in medical assessment. |
265 | $35 | $131 |
| Ultrasound of abdomen and pelvis blood flow An ultrasound exam that uses sound waves to visualize and assess blood flow through the arteries and veins in the abdomen and pelvis. |
247 | $113 | $457 |
| Chronic care management, first 20 min/month This service covers the first 20 minutes of clinical staff time directed by a healthcare professional each calendar month to manage chronic conditions. |
224 | $48 | $169 |
| Transrectal ultrasound of the pelvis An ultrasound imaging procedure where a probe is inserted into the rectum to visualize pelvic structures. |
181 | $118 | $386 |
| Electronic assessment of bladder emptying A test that uses electronic monitoring to evaluate how well the bladder empties urine. |
171 | $10 | $106 |
| Automated urinalysis An automated laboratory test performed on a urine sample to analyze its chemical and physical properties. The procedure uses machinery to detect various substances and cells within the urine. |
163 | $2 | $10 |
| Leuprolide acetate (for depot suspension), 7.5 mg | 123 | $136 | $800 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
85 | $10 | $50 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
59 | $117 | $448 |
| Complete pelvic ultrasound An imaging test using sound waves to create pictures of the organs and structures within the pelvis. |
48 | $57 | $296 |
| Subcutaneous or intramuscular chemotherapy injection This procedure involves administering anti-cancer hormonal medication through an injection into the tissue under the skin or into a muscle. |
42 | $26 | $100 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
21 | $77 | $302 |
| Office visit, established patient (10-19 min) An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition. |
15 | $42 | $153 |
| Office visit for established patient An office visit for an existing patient that may not require the healthcare professional to be present. |
13 | $14 | $63 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
12 | $133 | $519 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$122,971
Total received (2018-2024)
Avg $17,567/year across 7 years
Top 3% in PA for optician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
63
Companies
951
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$103,805 (84.4%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$16,729 (13.6%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$2,437 (2.0%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$13,209
2023
$22,145
2022
$41,837
2021
$26,079
2020
$1,916
2019
$12,522
2018
$5,264
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Sumitomo Pharma America, Inc.
$10,455
Janssen Biotech, Inc.
$491
ABBVIE INC.
$264
Tolmar, Inc.
$220
Dendreon Pharmaceuticals LLC
$216
Astellas Pharma US Inc
$209
Medtronic, Inc.
$182
Teleflex LLC
$170
PFIZER INC.
$144
Photocure Inc
$125
UROGEN PHARMA, INC.
$111
Endo USA, Inc.
$94
PROGENICS PHARMACEUTICALS, INC.
$84
Novartis Pharmaceuticals Corporation
$81
Tempus AI, Inc
$65
COLOPLAST CORP
$65
Boston Scientific Corporation
$55
Endo Pharmaceuticals Inc.
$52
Ferring Pharmaceuticals Inc.
$44
Daiichi Sankyo Inc.
$27
Merck Sharp & Dohme LLC
$20
Antares Pharma, Inc.
$18
Myriad Genetic Laboratories, Inc.
$17
Top 3 companies account for 84.9% of 2024 payments
All-time payments by company (2018-2024) ›
UROVANT SCIENCES INC
$62,044
Sumitomo Pharma America, Inc.
$29,731
Ferring Pharmaceuticals Inc.
$6,930
Amgen Inc.
$4,549
Aytu BioScience, Inc
$2,729
Janssen Biotech, Inc.
$2,147
Astellas Pharma US Inc
$1,891
AbbVie, Inc.
$1,505
Dendreon Pharmaceuticals LLC
$1,254
PFIZER INC.
$1,202
ABBVIE INC.
$718
Medtronic, Inc.
$683
Endo Pharmaceuticals Inc.
$616
Myovant Sciences Inc.
$594
Coloplast Corp
$513
Teleflex LLC
$487
Bayer HealthCare Pharmaceuticals Inc.
$420
Tolmar, Inc.
$358
Myriad Genetic Laboratories, Inc.
$354
AbbVie Inc.
$335
Boston Scientific Corporation
$303
Antares Pharma, Inc.
$295
AstraZeneca Pharmaceuticals LP
$294
TOLMAR Pharmaceuticals, Inc.
$260
Bayer Healthcare Pharmaceuticals Inc.
$220
UroGen Pharma, Inc.
$202
Avadel Specialty Pharmaceuticals, LLC
$190
UROGEN PHARMA, INC.
$153
Clarus Therapeutics Inc.
$134
Novartis Pharmaceuticals Corporation
$125
Photocure Inc
$125
BOSTON SCIENTIFIC CORPORATION
$101
Endo USA, Inc.
$94
Foundation Medicine, Inc.
$87
Agiliti Surgical, Inc.
$85
PROGENICS PHARMACEUTICALS, INC.
$84
COLOPLAST CORP
$79
ConvaTec Inc.
$76
MEDIVATION FIELD SOLUTIONS LLC
$71
180 Medical, Inc.
$67
ACCORD HEALTHCARE, INC.
$67
Tempus AI, Inc
$65
Acerus Pharmaceuticals Corporation
$65
Merck Sharp & Dohme LLC
$65
Progenics Pharmaceuticals, Inc.
$62
Ambu Inc.
$62
Merck Sharp & Dohme Corporation
$55
SUN PHARMACEUTICAL INDUSTRIES INC.
$53
GENZYME CORPORATION
$47
Verity Pharmaceuticals Inc.
$42
CONMED Corporation
$36
Alnylam Pharmaceuticals Inc.
$35
Wilmington Medical Supply, Inc.
$29
Baxter Healthcare
$28
Daiichi Sankyo Inc.
$27
Clovis Oncology, Inc.
$21
Profound Medical Corp.
$19
EMD Serono, Inc.
$18
Accord Healthcare, Inc.
$18
DENTSPLY IH AB
$17
Aesculap, Inc.
$17
Clinigen Inc
$14
Retrophin, Inc.
$6
Top 3 companies account for 80.3% of all-time payments
Associated products mentioned in payments ›
(815) Thiola · ADSTILADRIN · AIRSEAL · ALTIS · AMS · AMS 700 · AVEED · Altis · Androgel · BAVENCIO · BOTOX · BRACANALYSIS CDX · Balversa · CAIMAN VESSEL SEALERS · CAMCEVI · CYSVIEW · EDEX · ELIGARD · ERLEADA · EVENITY · Enhertu · Erleada · FEMALE INCONTINENCE · FIRMAGON · FOUNDATIONONE · GEMTESA · GENERAL BPH · GENTLECATH · GREENLIGHT · General - Erectile Dysfunction · INTERSTIM · JATENZO · JELMYTO · JEVTANA · KEYTRUDA · LITHOVUE · LUPRON DEPOT · LYNPARZA · LithoVue · LoFric · Lupron · Lupron Depot · MYRBETRIQ · Myrbetriq · NOCDURNA · Natesto · Noctiva · Nubeqa · ORGOVYX · OTREXUP · OXLUMO · Otrexup · PLUVICTO · PROLARIS · PROVENGE · PYLARIFY · Prolaris · Proleukin · Prolia · Rubraca · SEPRAFILM · Sonablate · SpaceOAR VUE System - 10mL · TITAN · TOVIAZ · Titan · Trelstar · UROLIFT · UroLift System · XGEVA · XIAFLEX · XTANDI · XYOSTED · Xofigo · Xtandi · YONSA · ZYTIGA
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
The majority of payments (84%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in optician and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 3% for optician in PA.
Geographic Context
Opticians within 10 mi
728
Per 100K population
46.0
County median income
$60,698
Nearest hospital
JEFFERSON EINSTEIN PHILADELPHIA HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Ginsberg is a mixed practice specialist, with above-average Medicare volume (top 1% in PA), with speaking/promotional industry engagement in the top 3% of PA peers, with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Ginsberg experienced with testosterone injection?
Based on Medicare claims data, Dr. Ginsberg performed 14,600 testosterone injection services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Ginsberg receive payments from pharmaceutical companies?
Yes. Dr. Ginsberg received a total of $122,971 from 63 companies across 951 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Ginsberg's costs compare to other opticians in Philadelphia?
Dr. Ginsberg's average Medicare payment per service is $12. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Ginsberg) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Opticians in Philadelphia
Browse opticians in Philadelphia ranked by procedure volume and transparency data.
Highest volume
Top Opticians in PA
Opticians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Opticians in PA
Which PA opticians receive the most from drug and device companies.
By company
UROVANT SCIENCES INC Payments to Doctors
See all physicians who received payments from UROVANT SCIENCES INC.
By company
Sumitomo Pharma America, Inc. Payments to Doctors
See all physicians who received payments from Sumitomo Pharma America, Inc.
By company
Ferring Pharmaceuticals Inc. Payments to Doctors
See all physicians who received payments from Ferring Pharmaceuticals Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology